KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Recursion Pharmaceuticals (RXRX) Short term Debt (2023 - 2025)

Historic Short term Debt for Recursion Pharmaceuticals (RXRX) over the last 3 years, with Q3 2025 value amounting to $8.9 million.

  • Recursion Pharmaceuticals' Short term Debt rose 851.69% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year increase of 851.69%. This contributed to the annual value of $8.4 million for FY2024, which is 2044878.05% up from last year.
  • According to the latest figures from Q3 2025, Recursion Pharmaceuticals' Short term Debt is $8.9 million, which was up 851.69% from $8.8 million recorded in Q2 2025.
  • Recursion Pharmaceuticals' Short term Debt's 5-year high stood at $8.9 million during Q3 2025, with a 5-year trough of $41000.0 in Q4 2023.
  • In the last 3 years, Recursion Pharmaceuticals' Short term Debt had a median value of $8.4 million in 2024 and averaged $7.3 million.
  • Its Short term Debt has fluctuated over the past 5 years, first skyrocketed by 2044878.05% in 2024, then surged by 792.95% in 2025.
  • Recursion Pharmaceuticals' Short term Debt (Quarter) stood at $41000.0 in 2023, then skyrocketed by 20448.78% to $8.4 million in 2024, then increased by 5.86% to $8.9 million in 2025.
  • Its Short term Debt was $8.9 million in Q3 2025, compared to $8.8 million in Q2 2025 and $8.6 million in Q1 2025.